# BLOOM-DM: Behavioral Modification and Lorcaserin for Overweight and Obesity Management in Diabetes Mellitus

> **NCT00603291** · PHASE3 · COMPLETED · sponsor: **Eisai Inc.** · enrollment: 604 (actual)

## Conditions studied

- Obesity

## Interventions

- **DRUG:** Lorcaserin 10 mg once daily (QD)
- **DRUG:** Lorcaserin 10 mg twice a day (BID)
- **DRUG:** Matching Placebo

## Key facts

- **NCT ID:** NCT00603291
- **Lead sponsor:** Eisai Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-12
- **Primary completion:** 2010-06
- **Final completion:** 2010-10
- **Target enrollment:** 604 (ACTUAL)
- **Last updated:** 2019-10-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00603291

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00603291, "BLOOM-DM: Behavioral Modification and Lorcaserin for Overweight and Obesity Management in Diabetes Mellitus". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00603291. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*